Robert Plenge tapped to run im­munol­o­gy R&D at Cel­gene; Tesaro files LAG-3 IND

→ Robert Plenge is tak­ing the plunge at Cel­gene. The ex-Mer­ck in­ves­ti­ga­tor is mov­ing out of Big Phar­ma to take charge of im­munol­o­gy re­search for the big biotech.

→ Pres­i­dent Trump had hoped to cut NIH spend­ing this year as he looked for cash to build a wall with Mex­i­co, among oth­er things. But Con­gress isn’t hav­ing any of it. Law­mak­ers agreed to a $2 bil­lion in­crease for the NIH in a spend­ing bill agreed to by De­moc­rats and Re­pub­li­cans late Sun­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.